correlation between the octreotide dose and injury score (p<003 for gastric injury, p<0-001 for duodenal injury). Conclusions-Octreotide protects the stomach from NSAID induced gastric injury, probably via its ability to reduce NSAID induced neutrophilic adhesion to the microvasculature. Octreotide also ameliorated indomethacin induced gastric and duodenal injury in humans. (Gut 1997; 40: 720-725) 
statin analogue octreotide prevents NSAID induced mucosal gastrointestinal damage in both animals and humans. The effect of octreotide on neutrophil adhesion to the endothelium was also evaluated. Methods-Male Sprague-Dawley rats were pretreated either with saline (0.3 ml subcutaneously) or octreotide (0.001-1 ng/ kg subcutaneously). After 30 minutes gastric ulcers were induced by the intragastric application of NSAIDs (20 mg/kg indomethacin, 200 mg/kg aspirin, 200 mg/ kg ibuprofen, or 50 mg/kg diclofenac). Four hours later the rats were killed and gastric mucosal lesions were assessed by computed planimetry. To determine whether octreotide could prevent indomethacin induced injury in humans, 20 healthy volunteers were evaluated in a double blind, placebo controlled study. Results-Octreotide prevented NSAID induced gastric mucosal lesions (p<0.05).
The dose response curve was U shaped and the most effective dose was 0 1 ng/kg. Leucocyte adherence in submucosal venules of the stomach was evaluated by in vivo microscopy. Octreotide (0 1 ng/kg subcutaneously) prevented indomethacin (20 mg/kg intragastric) induced leucocyte adherence in gastric submucosal venules (p<0.05). Healthy human volunteers received 50 mg indomethacin orally thrice a day concomitantly with either an identical placebo or 0-01 ,ug, 0.1 ,ug, or 1 ,ig octreotide subcutaneously thrice a day for three days. Injury was assessed by endoscopy. There was a negative correlation between the octreotide dose and injury score (p<003 for gastric injury, p<0-001 for duodenal injury). Conclusions-Octreotide protects the stomach from NSAID induced gastric injury, probably via its ability to reduce NSAID induced neutrophilic adhesion to the microvasculature. Octreotide also ameliorated indomethacin induced gastric and duodenal injury in humans. (Gut 1997; 40: 720-725) Keywords: gastric ulcer, microcirculation, somatostatin analogue, non-steroidal anti-inflammatory drugs.
Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are the predominant cause of gastric and duodenal ulcers unrelated to Helicobacter pylori infection. Although clinically apparent NSAID ulcers occur in a very small fraction of those using the medications, given the vast numbers of patients exposed, NSAID toxicity to the upper gastrointestinal tract represents a substantial clinical problem and is the most frequent side effect of drugs in the United States.' When studied by endoscopy, chronic NSAID users have been found to have gastric ulcers and erosions in 17% and 40% respectively, with duodenal ulcers and erosions seen in 4% and 130/2 3 Gastroduodenal injury related to NSAIDs may have ominous potential as these agents have been implicated in the development of complicated peptic ulcer disease, presenting without antecedent symptoms, requiring surgery or causing death. 4 The pathogenic mechanisms underlying NSAID related injury are complex, and reflect the ability of NSAIDs to have topical injurious effects which act in concert with systemic effects mediated by cyclooxygenase inhibition. Depletion of endogenous prostaglandins is thought to be central to the pathogenesis of NSAID related injury, based on the experimental evidence that antiprostaglandin antibodies induce ulcers in rabbits,5 and that oral administration of prostaglandins can reduce ulceration due to NSAIDs in humans. 6 Recent attention has focused on the ability of NSAIDs to promote neutrophil-endothelial adhesion with subsequent ulceration.7 Interference with this interaction using antibodies to cell adhesion molecules or neutrophil depletion prevented experimental NSAID induced ulcers in vivo.8 9 Somatostatin has been found to have gastroprotective properties against ethanol or NSAID induced ulcers in rats.'0 " The somatostatin analogue octreotide, at doses far below those necessary for the antisecretory actions of the drug, has also been shown to reduce ethanol induced mucosal lesions in rats.'2 The gastroprotective effect was mediated via prevention of microcirculatory stasis and increased vascular permeability. In rats, enhanced somatostatin gene expression was found after ethanol induced injury. '3 In support of the anti-inflammatory role of endogenous somatostatin, pretreatment with somatostatin monoclonal antibodies has been shown to exacerbate experimental colitis. 13 
720
Reduction of non-steroidal anti-inflammatory drug induced gastric injury and leucocyte endothelial adhesion by octreotide Somatostatin receptors have been identified on leucocytes,14 and octreotide has recently been shown to suppress effectively the inflammatory reaction in rat studies in vivo. '5 In the present paper, we studied the ability of octreotide to decrease NSAID induced injury in the stomach of rats. To examine the mechanism whereby octreotide may ameliorate NSAID ulcers, the effect of octreotide on indomethacin induced leucocyte-endothelial adherence was examined in postcapillary venules. The ability of octreotide to ameliorate endoscopically visible indomethacin induced gastric and duodenal injury was then examined in humans. Buchs, Switzerland) . Semithin sections (0 5 pum) were cut for evaluation and for photomicrography after toluidine blue staining.
Methods

IN VIVO MICROSCOPY PREPARATIONS
The animals were placed on an operating table (Harvard, Boston, USA) and the rectal temperature was maintained at 37°C throughout the experiments. To avoid aspiration the rats had endotracheal tubes placed after tracheotomy. The abdomen was then opened by midline laparotomy. The vena cava was cannulated for the application of the fluorescent tracer.
The leucocyte adherence in the submucosal venules was studied with a modified in vivo microscopy technique similar to the one described by Guth and Rosenberg."6 The posterior wall of the stomach was fixed with fast adhesive glue to a heated metal plate (37°C). The anterior wall of the stomach was fixed using a thin glass plate. The light of a mercury vapour lamp in the epi-illumination unit passed an excitation filter set (515-560 nm, dicroic mirror 580 nm, barrier filter 580 nm). The microcirculation was studied with a Nikon fluorescence objective 40/0-55 which resulted in final magnification on the video screen (Panasonic) of x 1500. A CCD video camera (Pieper, Germany) was attached to the microscope. The experiments were recorded on video tape (video recorder: Panasonic S-VHS). On review of the videotapes each image was digitalised with an image analysing system (Datacube, Peabody, MA, USA). Each (Fig 3a) , but the ever, the few mucosal lesions after pretreatment with octreotide had the same histological appearance as groups pretreated with vehicle.
LEUCOCYTE ADHERENCE IN RAT SUBMUCOSAL VENULES
Leucocyte adherence was measured in the submucosal venules of the stomach (Fig 4) . The effect of octreotide in ameliorati induced injury, however, followed U shaped dose-response curve. He vestigated the effect of octreotide mucosal lesions induced by indom similar dose-response relation was f the maximal effect at 0-1 ng/kg oct in the model of ethanol induced gast At this dose octreotide not only indomethacin induced gastric lesior mucosal lesions induced by aspirin, and diclofenac. Octreotide has been shown t NSAID induced gastric mucosal rats," but in this study the dose use orders of magnitude higher (10 ,ug/r our investigations. The hypothesisei isms for the observed action of hig octreotide -for example, inhibitic secretion, and decreased leukotrie ation and substance P and vasoactiv( polypeptide concentrations" -do n( the low doses we used. A biphasic dose relation in the ethanol gasi model was first noted by Diel and ' linear somatostatin. Laszlo Reduction of non-steroidal anti-inflammatory drug induced gastric injury and leucocyte endothelial adhesion by octreotide
In the present study we measured the in vivo leucocyte adherence induced by indomethacin in the postcapillary venules of the stomach. Indomethacin significantly increased leucocyte adherence to postcapillary venules of the mucosa. Octreotide also significantly reduced indomethacin induced leucocyte adherence. The protective effect of octreotide is therefore likely to be associated with its capacity to prevent indomethacin induced leucocyte adherence. Although not specifically considered in this study, the ability of octreotide to reduce NSAID induced neutrophil-endothelial interaction may reflect activation of the somatostatin receptors known to be present on mononuclear cells and vascular endothelium.14 21 The modulation by octreotide of the expression of mononuclear and endothelial cell adhesion molecules and cytokines are potential pathophysiological mechanisms which may explain our findings, but require further investigation.
The results of the double blind, placebo controlled study in humans confirm the ability of octreotide to prevent NSAID induced injury, extending the findings made in the rat model. Although not specifically studied in humans, the mechanism by which octreotide ameliorated the indomethacin induced injury is not likely to be related to antisecretory effects of the drug, as the doses utilised were one hundredth of the antisecretory doses utilised clinically. Based on the rat data, the ability of octreotide to reduce NSAID induced injury via effects on neutrophil adhesion represents a novel approach to the management of NSAID induced ulcer disease worthy of further study. A major limitation of octreotide for the current clinical management of NSAID induced ulcer is the requirement for parenteral administration. Given the low doses of octreotide used, the cost of medication is unlikely to represent a barrier to the clinical application of these findings. The development of oral octreotide analogues"9 will be of considerable interest for study as potential preventive agents of NSAID induced ulcers.
In summary, the present study considered the protective effect of octreotide in NSAID induced gastric ulceration. In rats, octreotide protects against indomethacin, aspirin, ibuprofen, and diclofenac induced gastric lesions, most likely via its ability to reduce NSAID induced neutrophil adhesion to the microvasculature. The potential for octreotide to reduce NSAID induced injury in humans was also confirmed.
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